Evolution of the Average Target: Arkema

Evolution of the Target Price: Arkema

Changes in Analyst Recommendations: Arkema

1720892457511c8550e3904c13817.XK6mqtrY-LyVr6B6zxuaQL9DbY95Azbe_QvgCnSz6OE.H5jc_uyTtfLR5tM-u3TiF8cGJr8NaGWEiDmiS0PKsJEr-pDciby3xcTm7Q~2475425208a4401b182e743182f357f4
08-12 Barclays Upgrades Arkema to Equalweight, Raises PT MT
07-30 Arkema: A strong Q2 but limited visibility for H2 Alphavalue
07-09 AlphaValue/Baader Europe Downgrades Arkema to Add, Cuts PT MT
07-09 Arkema: More cautious on demand and pricing Alphavalue
06-30 AlphaValue/Baader Europe Upgrades Arkema to Buy, Lifts PT MT
06-26 On Field Investment Research Downgrades Arkema to Neutral, Cuts PT MT
06-23 Deutsche Bank Raises Its Price Target on Arkema Zonebourse
06-08 Goldman Sachs Downgrades Arkema to Neutral, Lowers PT MT
06-08 Arkema retreats following Goldman Sachs downgrade Zonebourse
05-22 Analyst Ratings France: JP Morgan turns bearish on Arkema, HSBC raises Nexans target Zonebourse
05-07 Kepler Cheuvreux Downgrades Arkema to Reduce MT
05-06 Arkema: Key upstream solutions defend broader softness Alphavalue
05-04 Arkema holds firm despite AlphaValue downgrade Zonebourse
05-04 Arkema: A more conservative stance Alphavalue
04-20 Bernstein Upgrades Arkema to Market Perform, Boosts PT MT
04-20 Berenberg downgrades Arkema to Hold following recent share price rally Zonebourse
04-20 Arkema Downgraded to Hold as Berenberg Warns 'Good Times May Not Stick' MT
04-09 Arkema unmoved by Deutsche Bank note Zonebourse
03-27 Evonik hits annual high following Morgan Stanley upgrade DP
03-17 Sulfur and methanol prices soar on Middle East conflict Alphavalue
03-05 Berenberg Cuts Arkema EPS Projections After 'Tough' Q4 2025; Price Target Up MT
03-04 Middle East tensions intensify pessimism in chemicals Alphavalue
02-27 Kepler Cheuvreux Downgrades Arkema to Hold, Raises PT MT
02-27 Arkema: Earnings decline on soft demand and destocking Alphavalue
02-26 Arkema: Macroeconomic headwinds weigh on Arkema Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+14.74%
+3.15%
+6.6%
+20.7%
-7.32%
+7.73%
+26.31%
+27.85%
+4.87%
Average +11.63%
Weighted average by Cap. +11.16%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
60.10EUR
Average target price
62.93EUR
Spread / Average Target
+4.71%
High Price Target
80.00EUR
Spread / Highest target
+33.11%
Low Price Target
50.00EUR
Spread / Lowest Target
-16.81%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA